The mechanisms associated with the immunostimulatory activity of vaccine adjuvants are
still poorly understood. We have undertaken a study to determine whether antigen …

Adjuvants enhance antibody response against vaccination. We compared the ability of
MF59™-adjuvanted and non-adjuvanted subunit influenza vaccines, containing …

Life-long primary prevention interventions beginning and continuing throughout an
individual's lifetime are increasingly seen as key to meeting the global healthcare …

After priming with two intramuscular doses of MF59®-adjuvanted (Sub/MF59) or split
influenza vaccines during the 2006/07 season, 89 healthy children received a third booster …

Background: The higher effectiveness of MF59®-adjuvanted trivalent influenza vaccine
(MF59-TIV) vs. nonadjuvanted TIV in preventing influenza-related hospitalizations was …

Vaccines seek to adopt pathogen-like characteristics but not true pathogen characteristics to
activate the immune system without causing life-threatening disease. Vaccine formulations …

Original antigenic sin is a phenomenon wherein sequential exposure to closely related
influenza virus variants reduces antibody (Ab) response to novel antigenic determinants in …

The poor immunogenicity of peptide vaccines compared to conventional ones re usually
improved by applying different adjuvants. As chemical or biological substances, adjuvants …

The serious consequences of influenza infection during pregnancy have been recognized
for almost a century. In this article, we reviewed the evidence on the immunogenicity, safety …

Vaccines are among the greatest inventions in medicine, leading to the elimination or
control of numerous diseases, including smallpox, polio, measles, rubella, and, most …